[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100518120":3},{"organization":4,"armGroups":7,"interventions":38,"overallOfficials":56,"centralContacts":57,"locations":63,"responsibleParty":541,"collaborators":543,"id":546,"slug":56,"hasResults":547,"nctId":548,"briefTitle":549,"officialTitle":550,"acronym":551,"eligibilityCriteria":552,"healthyVolunteers":547,"sex":553,"minAge":554,"maxAge":56,"enrollmentInfo":555,"targetDuration":56,"studyType":558,"phases":559,"briefSummary":561,"conditions":562,"keywords":570,"overallStatus":66,"whyStopped":56,"lastUpdateSubmitDate":583,"lastUpdatePostDateStruct":584,"startDateStruct":587,"completionDateStruct":589,"leadSponsor":591,"locationsCount":592},{"fullName":5,"class":6},"Kura Oncology, Inc.","INDUSTRY",[8,14,19,24,28,31,34],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm #1: RAS-altered advanced solid tumors, monotherapy (escalation phase)","EXPERIMENTAL","Patients with advanced solid tumors and the following:\n\n* HRAS-mutant and\u002For amplified tumors (any solid tumor type)\n* HRAS overexpression (only for HNSCC tumors)\n* KRAS and\u002For NRAS and\u002For HRAS-mutant and\u002For amplified for NSCLC or CRC\n* KRAS-mutant and\u002For amplified PDAC",[13],"Drug: Darlifarnib",{"label":15,"type":10,"description":16,"interventionNames":17},"Arm #2: Advanced or metastatic RCC, combination therapy (escalation phase)","Patients who have received at least 1 prior systemic therapy with immuno-oncology (IO)-based treatment for locally advanced or metastatic RCC with predominantly clear cell subtype; non-clear cell RCC patients who are either treatment naïve or have received any prior systemic treatment for locally advanced and metastatic RCC",[13,18],"Drug: Cabozantinib",{"label":20,"type":10,"description":21,"interventionNames":22},"Arm #3: Advanced or metastatic NSCLC, CRC, or PDAC, combination therapy (escalation phase)","Patients with KRAS G12C-mutant locally advanced or metastatic NSCLC, CRC, or PDAC who have received at least 1 prior systemic therapy including available approved standard of care treatments",[13,23],"Drug: Adagrasib",{"label":25,"type":10,"description":26,"interventionNames":27},"Arm #4: Advanced or metastatic ccRCC, combination therapy (expansion phase)","Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC",[13,18],{"label":29,"type":10,"description":26,"interventionNames":30},"Arm #5: Advanced or metastatic ccRCC, monotherapy (expansion phase)",[18],{"label":32,"type":10,"description":26,"interventionNames":33},"Arm #6: Advanced or metastatic ccRCC, cabozantinib rollover to combination therapy (expansion phase)",[13,18],{"label":35,"type":10,"description":36,"interventionNames":37},"Arm #7: Advanced or metastatic NSCLC, combination therapy (expansion phase)","Patients with KRAS G12C-mutant locally advanced or metastatic NSCLC who have received at least 1 prior systemic therapy including available approved standard of care treatments",[13,23],[39,46,51],{"type":40,"name":41,"description":42,"armGroupLabels":43,"otherNames":44},"DRUG","Darlifarnib","Oral administration",[9,15,20,25,32,35],[45],"KO-2806",{"type":40,"name":47,"description":42,"armGroupLabels":48,"otherNames":49},"Cabozantinib",[15,25,29,32],[50],"Cabometyx",{"type":40,"name":52,"description":42,"armGroupLabels":53,"otherNames":54},"Adagrasib",[20,35],[55],"Krazati",null,[58],{"name":59,"role":60,"phone":61,"phoneExt":56,"email":62},"Kura Medical Information","CONTACT","844-KURAONC (844-587-2662)","medinfo@kuraoncology.com",[64,77,86,101,112,124,138,152,160,173,187,201,216,225,240,255,265,281,295,308,322,336,351,361,374,387,396,406,415,424,441,454,463,472,485,499,512,528],{"facility":65,"status":66,"city":67,"state":68,"zip":69,"country":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":56},"Mayo Clinic Comprehensive Cancer Center","RECRUITING","Phoenix","Arizona","85054","United States",{"type":72,"coordinates":73},"Point",[74,75],-112.07404,33.44838,{"lat":75,"lon":74},{"facility":78,"status":66,"city":79,"state":68,"zip":80,"country":70,"cosmosGeoPoint":81,"geoPoint":85,"contacts":56},"University of Arizona","Tucson","85724",{"type":72,"coordinates":82},[83,84],-110.92648,32.22174,{"lat":84,"lon":83},{"facility":87,"status":66,"city":88,"state":89,"zip":90,"country":70,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"University of Southern California","Los Angeles","California","90033",{"type":72,"coordinates":92},[93,94],-118.24368,34.05223,{"lat":94,"lon":93},[97],{"name":98,"role":60,"phone":99,"phoneExt":56,"email":100},"Xiomara Menendez, RN","323-865-3000","Xiomara.Menendez@med.usc.edu",{"facility":102,"status":66,"city":88,"state":89,"zip":103,"country":70,"cosmosGeoPoint":104,"geoPoint":106,"contacts":107},"Cedars-Sinai Medical Center","90048",{"type":72,"coordinates":105},[93,94],{"lat":94,"lon":93},[108],{"name":109,"role":60,"phone":110,"phoneExt":56,"email":111},"William Mills","310-423-0102","william.mills@cshs.org",{"facility":113,"status":66,"city":88,"state":89,"zip":114,"country":70,"cosmosGeoPoint":115,"geoPoint":117,"contacts":118},"UCLA Department of Medicine","90095",{"type":72,"coordinates":116},[93,94],{"lat":94,"lon":93},[119],{"name":120,"role":60,"phone":121,"phoneExt":122,"email":123},"Christopher Lim","310-633-8400","16043","christopherlim@mednet.ucla.edu",{"facility":125,"status":66,"city":126,"state":127,"zip":128,"country":70,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Sarah Cannon Research Institute at HealthONE","Denver","Colorado","80218",{"type":72,"coordinates":130},[131,132],-104.9847,39.73915,{"lat":132,"lon":131},[135],{"name":56,"role":60,"phone":136,"phoneExt":56,"email":137},"720-754-2610","CANN.DDUDenverGeneral@sarahcannon.com",{"facility":139,"status":66,"city":140,"state":141,"zip":142,"country":70,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"AdventHealth Celebration","Celebration","Florida","34747",{"type":72,"coordinates":144},[145,146],-81.53313,28.32529,{"lat":146,"lon":145},[149],{"name":150,"role":60,"phone":56,"phoneExt":56,"email":151},"Amy Whitaker","amy.whitaker@adventhealth.com",{"facility":65,"status":66,"city":153,"state":141,"zip":154,"country":70,"cosmosGeoPoint":155,"geoPoint":159,"contacts":56},"Jacksonville","32224",{"type":72,"coordinates":156},[157,158],-81.65565,30.33218,{"lat":158,"lon":157},{"facility":161,"status":66,"city":162,"state":141,"zip":163,"country":70,"cosmosGeoPoint":164,"geoPoint":168,"contacts":169},"Florida Cancer Specialists","Sarasota","34232",{"type":72,"coordinates":165},[166,167],-82.53065,27.33643,{"lat":167,"lon":166},[170],{"name":171,"role":60,"phone":56,"phoneExt":56,"email":172},"Nancy Olsen","nolsen@flcancer.com",{"facility":174,"status":66,"city":175,"state":176,"zip":177,"country":70,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"University of Iowa Hospitals & Clinics","Iowa City","Iowa","52242",{"type":72,"coordinates":179},[180,181],-91.53017,41.66113,{"lat":181,"lon":180},[184],{"name":185,"role":60,"phone":186,"phoneExt":56,"email":56},"Mimi McKay","319-353-8155",{"facility":188,"status":66,"city":189,"state":190,"zip":191,"country":70,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"Dana-Farber Cancer Institute","Boston","Massachusetts","02215",{"type":72,"coordinates":193},[194,195],-71.05977,42.35843,{"lat":195,"lon":194},[198],{"name":199,"role":60,"phone":56,"phoneExt":56,"email":200},"Kailene Sullivan, RN","kailene_sullivan@dfci.harvard.edu",{"facility":202,"status":66,"city":203,"state":204,"zip":205,"country":70,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Henry Ford Health System","Detroit","Michigan","48202",{"type":72,"coordinates":207},[208,209],-83.04575,42.33143,{"lat":209,"lon":208},[212],{"name":213,"role":60,"phone":214,"phoneExt":56,"email":215},"Bethany Adams, RN","248-224-7345","badams19@HFHS.ORG",{"facility":65,"status":66,"city":217,"state":218,"zip":219,"country":70,"cosmosGeoPoint":220,"geoPoint":224,"contacts":56},"Rochester","Minnesota","55905",{"type":72,"coordinates":221},[222,223],-92.4699,44.02163,{"lat":223,"lon":222},{"facility":226,"status":66,"city":227,"state":228,"zip":229,"country":70,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"Washington University School of Medicine","St Louis","Missouri","63110",{"type":72,"coordinates":231},[232,233],-90.19789,38.62727,{"lat":233,"lon":232},[236],{"name":237,"role":60,"phone":238,"phoneExt":56,"email":239},"Jessica Ley","314-747-8092","jcley@wustl.edu",{"facility":241,"status":66,"city":242,"state":243,"zip":244,"country":70,"cosmosGeoPoint":245,"geoPoint":249,"contacts":250},"Rutgers Cancer Institute of New Jersey","New Brunswick","New Jersey","08901",{"type":72,"coordinates":246},[247,248],-74.45182,40.48622,{"lat":248,"lon":247},[251],{"name":252,"role":60,"phone":253,"phoneExt":56,"email":254},"Mohammad Ghalib","718-405-8515","mhg68@cinj.rutgers.edu",{"facility":256,"status":66,"city":257,"state":258,"zip":259,"country":70,"cosmosGeoPoint":260,"geoPoint":264,"contacts":56},"Ohio State University","Columbus","Ohio","43210",{"type":72,"coordinates":261},[262,263],-82.99879,39.96118,{"lat":263,"lon":262},{"facility":266,"status":66,"city":267,"state":268,"zip":269,"country":70,"cosmosGeoPoint":270,"geoPoint":274,"contacts":275},"OU Stephenson Cancer Center","Oklahoma City","Oklahoma","73104",{"type":72,"coordinates":271},[272,273],-97.51643,35.46756,{"lat":273,"lon":272},[276],{"name":277,"role":60,"phone":278,"phoneExt":279,"email":280},"Christina Caldwell","405-271-8001","48171","Christina-Caldwell@ouhsc.edu",{"facility":282,"status":66,"city":283,"state":284,"zip":285,"country":70,"cosmosGeoPoint":286,"geoPoint":290,"contacts":291},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15232",{"type":72,"coordinates":287},[288,289],-79.99589,40.44062,{"lat":289,"lon":288},[292],{"name":293,"role":60,"phone":56,"phoneExt":56,"email":294},"Immunotherapy and Drug Development Center (IDDC) Referrals","ClinicalResearchServicesHCCIDDC@upmc.edu",{"facility":296,"status":66,"city":297,"state":298,"zip":299,"country":70,"cosmosGeoPoint":300,"geoPoint":304,"contacts":305},"SCRI - Oncology Partners","Nashville","Tennessee","37203",{"type":72,"coordinates":301},[302,303],-86.78444,36.16589,{"lat":303,"lon":302},[306],{"name":56,"role":60,"phone":307,"phoneExt":56,"email":56},"844-482-4812",{"facility":309,"status":66,"city":310,"state":311,"zip":312,"country":70,"cosmosGeoPoint":313,"geoPoint":317,"contacts":318},"UT Southwestern Simmons Cancer Center","Dallas","Texas","75235",{"type":72,"coordinates":314},[315,316],-96.80667,32.78306,{"lat":316,"lon":315},[319],{"name":320,"role":60,"phone":56,"phoneExt":56,"email":321},"Tian Zhang, MD","Tian.Zhang@utsouthwestern.edu",{"facility":323,"status":66,"city":324,"state":311,"zip":325,"country":70,"cosmosGeoPoint":326,"geoPoint":330,"contacts":331},"MD Anderson Cancer Center","Houston","77030",{"type":72,"coordinates":327},[328,329],-95.36327,29.76328,{"lat":329,"lon":328},[332],{"name":333,"role":60,"phone":334,"phoneExt":56,"email":335},"Ly M Nguyen","(832) 794-3672","lmnguyen1@mdanderson.org",{"facility":337,"status":66,"city":338,"state":339,"zip":340,"country":70,"cosmosGeoPoint":341,"geoPoint":345,"contacts":346},"University of Wisconsin (Carbone Cancer Center)","Madison","Wisconsin","53792",{"type":72,"coordinates":342},[343,344],-89.40123,43.07305,{"lat":344,"lon":343},[347],{"name":348,"role":60,"phone":349,"phoneExt":56,"email":350},"UW Carbone Cancer Center - Cancer Connect","800-622-8922","clinicaltrials@cancer.wisc.edu",{"facility":352,"status":66,"city":353,"state":56,"zip":354,"country":355,"cosmosGeoPoint":356,"geoPoint":360,"contacts":56},"Centre Leon Berard","Lyon","69495","France",{"type":72,"coordinates":357},[358,359],4.84789,45.74906,{"lat":359,"lon":358},{"facility":362,"status":66,"city":363,"state":56,"zip":364,"country":355,"cosmosGeoPoint":365,"geoPoint":369,"contacts":370},"Oncologie médicale - Pitié-Salpêtrière","Paris","75013",{"type":72,"coordinates":366},[367,368],2.3488,48.85341,{"lat":368,"lon":367},[371],{"name":372,"role":60,"phone":56,"phoneExt":56,"email":373},"Marianne Veyri","marianne.veyri@aphp.fr",{"facility":375,"status":66,"city":363,"state":56,"zip":376,"country":355,"cosmosGeoPoint":377,"geoPoint":379,"contacts":380},"Hopital Européen Georges Pompidou","75015",{"type":72,"coordinates":378},[367,368],{"lat":368,"lon":367},[381,384],{"name":382,"role":60,"phone":56,"phoneExt":56,"email":383},"Anna Farran","anna.farran@aphp.fr",{"name":385,"role":60,"phone":56,"phoneExt":56,"email":386},"Clémentine Drain","clementine.drain@aphp.fr",{"facility":388,"status":66,"city":389,"state":56,"zip":390,"country":355,"cosmosGeoPoint":391,"geoPoint":395,"contacts":56},"Institut Universitaire du Cancer Toulouse - Oncopole","Toulouse","31059",{"type":72,"coordinates":392},[393,394],1.44367,43.60426,{"lat":394,"lon":393},{"facility":397,"status":66,"city":398,"state":56,"zip":399,"country":400,"cosmosGeoPoint":401,"geoPoint":405,"contacts":56},"Charité - Universitätsmedizin Berlin","Berlin","12203","Germany",{"type":72,"coordinates":402},[403,404],13.41053,52.52437,{"lat":404,"lon":403},{"facility":407,"status":66,"city":408,"state":56,"zip":409,"country":400,"cosmosGeoPoint":410,"geoPoint":414,"contacts":56},"Universitätsklinikum Ulm","Ulm","89081",{"type":72,"coordinates":411},[412,413],9.99155,48.39841,{"lat":413,"lon":412},{"facility":416,"status":66,"city":417,"state":56,"zip":418,"country":400,"cosmosGeoPoint":419,"geoPoint":423,"contacts":56},"Universitätsklinikum Würzburg","Würzburg","97080",{"type":72,"coordinates":420},[421,422],9.95121,49.79391,{"lat":422,"lon":421},{"facility":425,"status":66,"city":426,"state":56,"zip":427,"country":428,"cosmosGeoPoint":429,"geoPoint":433,"contacts":434},"Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS","Bologna","40138","Italy",{"type":72,"coordinates":430},[431,432],11.33875,44.49381,{"lat":432,"lon":431},[435,438],{"name":436,"role":60,"phone":56,"phoneExt":56,"email":437},"Serena Aloi","serena.aloi@aosp.bo.it",{"name":439,"role":60,"phone":56,"phoneExt":56,"email":440},"Mirela Giordano","mirela.giordano@aosp.bo.it",{"facility":442,"status":66,"city":443,"state":56,"zip":444,"country":428,"cosmosGeoPoint":445,"geoPoint":449,"contacts":450},"Fondazione Piemonte per l'Oncologia - IRCCs Candiolo","Candiolo","10060",{"type":72,"coordinates":446},[447,448],7.59812,44.95858,{"lat":448,"lon":447},[451],{"name":452,"role":60,"phone":56,"phoneExt":56,"email":453},"Vanesa Gregorc, MD","Vanesa.gregorc@ircc.it",{"facility":455,"status":66,"city":456,"state":56,"zip":457,"country":428,"cosmosGeoPoint":458,"geoPoint":462,"contacts":56},"Istituto Nazionale Tumori IRCCS","Naples","80131",{"type":72,"coordinates":459},[460,461],14.26811,40.85216,{"lat":461,"lon":460},{"facility":464,"status":66,"city":465,"state":56,"zip":466,"country":428,"cosmosGeoPoint":467,"geoPoint":471,"contacts":56},"Humanitas University","Rozzano","20089",{"type":72,"coordinates":468},[469,470],9.1559,45.38193,{"lat":470,"lon":469},{"facility":473,"status":66,"city":474,"state":56,"zip":475,"country":428,"cosmosGeoPoint":476,"geoPoint":480,"contacts":481},"AOU Verona - Centro Ricerche Cliniche di Verona","Verona","37134",{"type":72,"coordinates":477},[478,479],10.9938,45.43854,{"lat":479,"lon":478},[482],{"name":483,"role":60,"phone":56,"phoneExt":56,"email":484},"Andrea Zivi, MD","andrea.zivi@aovr.veneto.it",{"facility":486,"status":66,"city":487,"state":56,"zip":488,"country":489,"cosmosGeoPoint":490,"geoPoint":494,"contacts":495},"Hospital Universitari Vall d'Hebron","Barcelona","08035","Spain",{"type":72,"coordinates":491},[492,493],2.15899,41.38879,{"lat":493,"lon":492},[496],{"name":497,"role":60,"phone":56,"phoneExt":56,"email":498},"Paula Barranco","paulabarranco@vhio.net",{"facility":500,"status":66,"city":487,"state":56,"zip":501,"country":489,"cosmosGeoPoint":502,"geoPoint":504,"contacts":505},"Hospital de la Santa Creu i de Sant Pau","08041",{"type":72,"coordinates":503},[492,493],{"lat":493,"lon":492},[506,509],{"name":507,"role":60,"phone":56,"phoneExt":56,"email":508},"Mireia Llobet Busquets","mllobetb@santpau.cat",{"name":510,"role":60,"phone":56,"phoneExt":56,"email":511},"Phase 1 Center","IR_fases1onco@santpau.cat",{"facility":513,"status":66,"city":514,"state":56,"zip":515,"country":489,"cosmosGeoPoint":516,"geoPoint":520,"contacts":521},"Hospital HM Sanchinarro START Madrid-CIOCC","Madrid","28050",{"type":72,"coordinates":517},[518,519],-3.70256,40.4165,{"lat":519,"lon":518},[522,525],{"name":523,"role":60,"phone":56,"phoneExt":56,"email":524},"Maria Garrido, RN","maria.garrido@startmadrid.com",{"name":526,"role":60,"phone":56,"phoneExt":56,"email":527},"Esther Ordoñez","esther.ordonez@startmadrid.com",{"facility":529,"status":66,"city":530,"state":56,"zip":531,"country":489,"cosmosGeoPoint":532,"geoPoint":536,"contacts":537},"Hospital Universitario Virgen del Rocío","Seville","41013",{"type":72,"coordinates":533},[534,535],-5.97317,37.38283,{"lat":535,"lon":534},[538],{"name":539,"role":60,"phone":56,"phoneExt":56,"email":540},"Rosa María Ballesteros","rballesteros.oncologiahuvr@gmail.com",{"type":542,"investigatorFullName":56,"investigatorTitle":56,"investigatorAffiliation":56,"oldNameTitle":56,"oldOrganization":56},"SPONSOR",[544],{"name":545,"class":6},"Mirati Therapeutics Inc.","100518120",false,"NCT06026410","KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors","Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of KO-2806 When Administered as Monotherapy and in Combination Therapy in Adult Patients With Advanced Solid Tumors","FIT-001","Inclusion Criteria:\n\n* At least 18 years of age.\n* Histologically or cytologically confirmed advanced solid tumors\n\n  * Arm #1 (KO-2806 monotherapy): Patients who have progressed on, or are refractory to, standard of care (SOC) treatments with advanced solid tumors, specifically: HRAS-mutant and\u002For amplified tumors (any solid tumor type); HRAS overexpression (only for HNSCC tumors); KRAS and\u002For NRAS, and\u002For HRAS-mutant and\u002For amplified NSCLC or CRC; KRAS-mutant and\u002For amplified PDAC\n  * Arm #2 (Combination): Patients who have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic RCC with predominantly clear cell subtype; non-clear cell RCC patients who are either treatment-naïve or have received any prior systemic treatment for locally advanced and metastatic RCC.\n  * Arm #3 (Combination): Patients who have received at least 1 prior systemic therapy including available approved SOC treatments for KRAS G12C-mutant locally advanced or metastatic NSCLC, CRC, or PDAC.\n  * Arm #4 (Combination): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #5 (Cabozantinib monotherapy): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #6 (Cabozantinib rollover to combination): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #7 (Combination): Patients who have received at least 1 prior systemic therapy including available approved SOC treatments for KRAS G12C-mutant locally advanced or metastatic NSCLC\n* Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.\n* Karnofsky Performance Status of 70 or higher with no clinically significant deterioration over the previous 2 weeks.\n* Acceptable liver, renal, endocrine, and hematologic function.\n* Other protocol-defined inclusion criteria may apply.\n\nExclusion Criteria:\n\n* Any use of anticancer therapy within 14 days or 5 half-lives (whichever is shorter) of Cycle 1 Day 1.\n* Prior treatment with an FTI or HRAS inhibitor.\n* Major surgery, other than local procedures, within 28 days prior to Cycle 1 Day 1, without complete recovery.\n* Spinal cord compression, leptomeningeal disease, or clinically active CNS metastases.\n* Toxicity (excluding alopecia) from prior therapy that has not been completely resolved to baseline at the time of consent.\n* Active or prior documented autoimmune or inflammatory disorders within the past 5 years prior to Cycle 1 Day 1 (with exceptions).\n* Active, uncontrolled bacterial, viral, or fungal infections requiring systemic therapy.\n* Inability to swallow, impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of the trial drugs.\n* Inadequate cardiac and\u002For vascular function, including receipt of treatment for unstable angina, myocardial infarction, and\u002For cerebrovascular attack within the prior 6 months, mean QTcF ≥470 ms, or Class II or greater congestive heart failure.\n* Other invasive malignancy within 2 years.\n* Other protocol-defined exclusion criteria may apply.","ALL","18 Years",{"count":556,"type":557},300,"ESTIMATED","INTERVENTIONAL",[560],"PHASE1","This first-in-human (FIH) dose-escalation and dose-validation\u002Fexpansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.",[563,564,565,566,567,568,569],"Solid Tumors With HRAS Alterations","Non Small Cell Lung Cancer (NSCLC)","Colorectal Cancer (CRC)","Pancreatic Ductal Adenocarcinoma (PDAC)","Clear Cell Renal Cell Carcinoma (ccRCC)","Renal Cell Carcinoma (Kidney Cancer)","Non Clear Cell Renal Cell Carcinoma (nccRCC)",[571,572,573,574,575,576,577,578,579,580,581,582],"HRAS","KRAS","NRAS","Farnesyltransferase inhibitor (FTI)","Tyrosine Kinase inhibitor (TKI)","Phase 1","KRAS G12C inhibitor","NSCLC","ccRCC","RCC","PDAC","CRC","2026-06-04",{"date":585,"type":586},"2026-06-08","ACTUAL",{"date":588,"type":586},"2023-10-18",{"date":590,"type":557},"2027-04",{"name":5,"class":6},38]